West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Macquarie Group Ltd.

Macquarie Group Ltd. boosted its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 174,081.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 57,480 shares of the medical instruments supplier’s stock after purchasing an additional 57,447 shares during the period. Macquarie Group Ltd. owned approximately 0.08% of West Pharmaceutical Services worth $5,433,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in West Pharmaceutical Services by 0.3% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,735 shares of the medical instruments supplier’s stock worth $1,015,000 after purchasing an additional 34 shares during the period. Cambridge Investment Research Advisors Inc. raised its stake in West Pharmaceutical Services by 1.6% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock worth $210,000 after purchasing an additional 40 shares during the period. Teacher Retirement System of Texas raised its stake in West Pharmaceutical Services by 0.7% during the second quarter. Teacher Retirement System of Texas now owns 5,867 shares of the medical instruments supplier’s stock worth $555,000 after purchasing an additional 40 shares during the period. Hillsdale Investment Management Inc. raised its stake in West Pharmaceutical Services by 0.7% during the second quarter. Hillsdale Investment Management Inc. now owns 12,080 shares of the medical instruments supplier’s stock worth $1,142,000 after purchasing an additional 80 shares during the period. Finally, PNC Financial Services Group Inc. raised its stake in West Pharmaceutical Services by 2.6% during the first quarter. PNC Financial Services Group Inc. now owns 6,806 shares of the medical instruments supplier’s stock worth $556,000 after purchasing an additional 175 shares during the period. 90.17% of the stock is currently owned by institutional investors.

Shares of West Pharmaceutical Services, Inc. (WST) traded down 0.60% during midday trading on Friday, hitting $100.32. 67,753 shares of the company’s stock were exchanged. West Pharmaceutical Services, Inc. has a one year low of $70.85 and a one year high of $101.59. The firm has a market cap of $7.42 billion, a PE ratio of 43.06 and a beta of 1.12. The stock’s 50-day moving average price is $93.83 and its 200 day moving average price is $91.98.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.53 by $0.14. The business had revenue of $398.20 million for the quarter, compared to analyst estimates of $386.02 million. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The company’s revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.53 EPS. Equities research analysts forecast that West Pharmaceutical Services, Inc. will post $2.67 EPS for the current year.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2017/10/27/west-pharmaceutical-services-inc-wst-shares-bought-by-macquarie-group-ltd.html.

A number of equities analysts have commented on the stock. Wells Fargo & Company lifted their target price on shares of West Pharmaceutical Services from $105.00 to $112.00 and gave the stock an “outperform” rating in a research note on Friday. Bank of America Corporation cut shares of West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price target for the company. in a research report on Tuesday, October 17th. Stephens began coverage on shares of West Pharmaceutical Services in a research report on Tuesday, October 3rd. They set an “equal weight” rating and a $99.00 price target for the company. Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research report on Wednesday, September 27th. Finally, Jefferies Group LLC upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and lifted their price target for the company from $96.00 to $115.00 in a research report on Friday, September 15th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $106.00.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply